Home › Kidney Cancer (Renal Cell Carcinoma) › Louisiana › New Orleans
Kidney Cancer (Renal Cell Carcinoma) clinical trials in New Orleans, LA
5 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around New Orleans (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RecruitingPhase 1
- Research Site, New Orleans
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- University Medical Center New Orleans, New Orleans
- Touro Infirmary, New Orleans
- West Jefferson Medical Center, Marrero · 4 mi away
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecruitingObservational study
- Tulane Cancer Center, New Orleans
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RecruitingPhase 3
- Ochsner Medical Center Jefferson, New Orleans
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- Louisiana State University Health Science Center, New Orleans
- Tulane University Health Sciences Center, New Orleans
- University Medical Center New Orleans, New Orleans
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- Dallas, TX23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Philadelphia, PA15 studies
- Pittsburgh, PA15 studies
- Queens, NY15 studies
- Rochester, MN14 studies
Other studies in New Orleans
- Cancer (all types)12 studies
- Ovarian Cancer12 studies
- Breast Cancer11 studies
- Prostate Cancer10 studies
- Endometrial Cancer9 studies
- Metastatic Cancer9 studies
- Lung Cancer9 studies
- Non-Small Cell Lung Cancer9 studies
- Cardiovascular Disease9 studies
- Obesity8 studies
- Steatotic Liver Disease8 studies
- Colorectal Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.